₹196-₹208 Issue Size
₹30.24 Cr.
₹2,35,200.00 Max Bid
₹5,00,000.00
1453800 Min Qty
1200
NSE
About Avience Biomedicals Limited
Avience Biomedicals IPO is a book build issue of Rs 30.24 crores. The issue is entirely a fresh issue of 0.15 crore shares of Rs 30.24 crore.
Avience Biomedicals IPO opens for subscription on Jun 18, 2026 and closes on Jun 22, 2026. The allotment for the Avience Biomedicals IPO is expected to be finalized on Jun 23, 2026. Avience Biomedicals IPO will list on the NSE SME with a tentative listing date fixed as Jun 25, 2026.
Avience Biomedicals IPO is set issue price band at Rs 196 to Rs 208 per share. The lot size for an application is 600 shares. The minimum amount of investment required by an individual investor (retail) is Rs 2,49,600 (1,200 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (1,800 shares), amounting to Rs 3,74,400.
Fintellectual Corporate Advisors Pvt.Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Asnani Stock Broker Pvt.Ltd.
Avience Biomedicals Limited Timeline
| Issue open date | 18 Jun 2026 10 AM |
| Issue close date | 22 Jun 2026 5 PM |
| Allotment finalization | 23 Jun 2026 |
| Refund initiation | 24 Jun 2026 |
| Share credit | 24 Jun 2026 |
| Listing date | 25 Jun 2026 |